Andrew Orth
Förmögenhet: 24 M $ per 2026-09-30
Förmögenhet: 24 M $ per 2026-09-30
Mr. Andrew C.
Orth is a President, Chief Executive Officer & Director at City Therapeutics, Inc. He is on the Board of Directors at City Therapeutics, Inc. Mr. Orth was previously employed as a Chief Commercial Officer by Krystal Biotech, Inc. and a Senior Vice President & Head-US Busines by Alnylam Pharmaceuticals, Inc. He received his undergraduate degree from the University of Wisconsin and an MBA from Johnson Graduate School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
2,06 % | 2026-10-19 | 1 063 154 ( 2,06 % ) | 24 M $ | 2026-09-30 |
| Företag | Position | Start |
|---|
| Företag | Position | Slut |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Företagsledare/Principal | 2023-08-02 |
| BIOGEN INC. | Företagsledare/Principal | 2016-01-01 |
| ALNYLAM PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån